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(1) Hyperglycemia leads to cytotoxicity in the heart. Although several theories are postulated for glucose toxicity-induced
cardiomyocyte dysfunction, the precise mechanism still remains unclear. (2) This study was designed to evaluate the impact
of elevated extracellular Ca2+ on glucose toxicity-induced cardiac contractile and intracellular Ca2+ anomalies as well as the
mechanism(s) involved with a focus on Ca2+/calmodulin (CaM)-dependent kinase. Isolated adult rat cardiomyocytes were
maintained in normal (NG, 5.5mM) or high glucose (HG, 25.5mM) media for 6-12 hours. Contractile indices were measured
including peak shortening (PS), maximal velocity of shortening/relengthening (±dL/dt), time-to-PS (TPS), and time-to-90%
relengthening (TR90). (3) Cardiomyocytes maintained with HG displayed abnormal mechanical function including reduced PS,
±dL/dt, and prolonged TPS, TR90 and intracellular Ca2+ clearance. Expression of intracellular Ca2+ regulatory proteins including
SERCA2a, phospholamban and Na+-Ca2+ exchanger were unaﬀected whereas SERCA activity was inhibited by HG. Interestingly,
the HG-induced mechanical anomalies were abolished by elevated extracellular Ca2+ (from 1.0 to 2.7mM). Interestingly, the high
extracellular Ca2+-induced beneﬁcial eﬀect against HG was abolished by the CaM kinase inhibitor KN93. (4) These data suggest
that elevated extracellular Ca2+ protects against glucose toxicity-induced cardiomyocyte contractile defects through a mechanism
associated with CaM kinase.
1.Introduction
Hyperglycemia in individuals with diabetes mellitus usually
compromises myocardial contractile function and energy
metabolism independent of macro- and microvascular coro-
nary anomalies [1–4]. Hyperglycemia-associated patholog-
ical changes in the heart are characterized by myocardial
damage, cardiac hypertrophy, overt ﬁbrosis, structural and
functional changes of myocardium, and cardiac autonomic
neuropathy [4]. A number of theories have been postulated
for hyperglycemia-induced myocardial dysfunction includ-
ingdirectglucosetoxicity,impairedglucosemetabolism,dis-
rupted energy metabolism, oxidative stress, and interrupted
intracellular Ca2+ homeostasis [4–8]. Despite the fact that
these factors may contribute to cardiac contractile anomalies
and tissue damage in hyperglycemic condition, the ultimate
cause responsible for the hyperglycemia- and diabetes-
triggeredmyopathicchangeremainselusive.Recentevidence
has suggested a role of impaired energy metabolism and
energy reserve in hyperglycemia-associated cardiac contrac-
tile impairment [9, 10]. Along the same line, reports from
our laboratory as well as others have revealed that the cell
energy fuel AMP-dependent protein kinase (AMPK) and
the essential energy substrate pyruvate protect against car-
diomyocyte contractile dysfunction under hyperglycemic or
metabolic derangement conditions [11–13]. However, the
precisenaturebehindAMPKandpyruvate-improvedcardiac
contractile function under hyperglycemic or diabetic condi-
tion remains unclear.2 Experimental Diabetes Research
Ca2+/calmodulin-dependent protein kinase II (CaMKII),
a serine-threonine protein kinase implicated in a variety of
cardiovascular regulation, was found with high activity in
brains under diabetes, possibly contributes to neuronal cell
death [14, 15]. Interestingly, CaMKII also promotes cell
survival in response to various stresses [16, 17], thus making
CaMKII an important point of intersection for diﬀerent
pathways involved in diseases. To this end, this study was
designed to examine the impact of elevated extracellular
Ca2+ levels mimicking a higher cardiac energy supply on
cardiomyocyte contractile function and intracellular Ca2+
handling in cardiomyocytes maintained in normal glucose
(NG) or high glucose (HG) environment. Levels and activ-
ity of the intracellular Ca2+ regulatory proteins including
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA), phos-
pholamban, and Na+/Ca2+ exchanger were examined.
2. Methods
2.1. Isolation and Culture of Rat Cardiomyocytes. The exper-
imental procedures used in this study were approved by
the Animal Use and Care Committee at the University of
Wyoming (Laramie,WY,USA).In brief, adultmale Sprague-
Dawley rats (200–250g) were anesthetized using ketamine/
xylazine (5:3, 1.32mg/kg i.p.). Hearts were rapidly removed
a n dp e r f u s e d( a t3 7 ◦C) with the Krebs-Henseleit bicarbon-
ate (KHB) buﬀer (mM: NaCl 118, KCl 4.7, MgSO4 1.2,
KH2PO4 1.2, NaHCO3 25, N-[2-hydro-ethyl]-piperazine-
N -[2-ethanesulfonic acid] (HEPES) 10, glucose 11.1; pH
7.4).Theheartwasperfusedfor20minwithKHBcontaining
176 U/mL collagenase II (Worthington Biochemical Corp.,
Freehold, NJ, USA) and 0.5mg/mL hyaluronidase. After
perfusion, left ventricles were removed and minced. The
cells were further digested with 0.02mg/mL trypsin before
being ﬁltered through a nylon mesh (300µm). Extracellular
Ca2+ was added incrementally back to 1.25mM. Isolated car-
diomyocyteswereculturedonglasscoverslipsprecoatedwith
laminin (10µg/mL) and maintained for 6 or 12 hours in a
deﬁned medium consisting of Medium 199 with Earle’s salts
containing 25mM HEPES and NaHCO3 supplemented with
albumin (2mg/mL), L-carnitine (2mM), creatine (5mM),
taurine (5mM), insulin (0.1µM), penicillin (100U/mL),
streptomycin (100µg/mL), and gentamicin (100µg/mL).
This medium also contained either normal glucose (NG:
5.5mM)orhighglucose(HG:25.5mM)concentrations.The
high glucose concentration is comparable to serum glucose
levels in severely diabetic rats [18]. Subsets of NG and HG
media were supplemented with the glycation inhibitor
aminoguanidine (1mM) [19] or the translation inhibitor
cycloheximide (60µm) [20]. DMSO was used as a solvent
with a ﬁnal concentration less than 0.5%. These inhibitors
were added at the time when myocytes were placed in
medium,andcellswereincubatedfor12hoursat37◦Cunder
100% humidity and 5% CO2 [21].
2.2. Cell Shortening/Relengthening. Mechanical properties of
cardiomyocytes were assessed using a video-based edge-
detection system (IonOptix Corporation, Milton, MA, USA)
as described previously [21]. In brief, cardiomyocytes were
superfused at 25◦Cw i t hab u ﬀer containing (in mM)
131 NaCl, 4 KCl, 1 CaCl2,1M g C l 2,1 0g l u c o s e ,a n d1 0
HEPES, at pH 7.4. The cells were ﬁeld stimulated at 0.5Hz.
Cardiomyocytes were displayed on a computer monitor
using a Pulnix variable speed camera, which rapidly scans
image areas every 8.3msec such that the amplitude of
shortening/relengthening is recorded with good ﬁdelity.
A cohort of cardiomyocytes was recorded in the above-
mentioned recording buﬀer with the exception of a higher
extracellular Ca2+ level at 2.7mM in the absence or presence
of the CaM kinase inhibitor 2-[N-(2-hydroxyethyl)]-N-(4-
methoxybenzenesulfonyl)amino-N-(4-chloro-cinnamyl)-
N-methylbenzylamine (KN93, 10µM) [20].
2.3. Intracellular Ca2+ Transients. Isolated cardiomyocytes
were loaded with fura-2/AM (0.5µM) for 10min. Fluores-
cence intensity was recorded using a dual-excitation ﬂuores-
cence photomultiplier system (IonOptix). Cardiomyocytes
wereplacedontoanOlympusIX-70invertedmicroscopeand
imaged through a Fluor 40x oil objective. Cells were exposed
to light emitted by a 75W lamp and passed through either
a 360 or a 380nm ﬁlter while being stimulated to contract
at 0.5Hz. Fluorescence emissions were detected between 480
and 520nm, and qualitative change in fura-2 ﬂuorescence
intensity was inferred from the fura-2 ﬂuorescence intensity
ratioatthe2wavelengths(360/380).Fluorescencedecaytime
was calculated as an indicator of intracellular Ca2+ clearance
[22].
2.4. Western Blotting. Protein samples for western blotting
were prepared as described [22]. Brieﬂy, cardiomyocytes
were homogenized and sonicated in a lysis buﬀer con-
taining 20mM Tris (pH 7.4), 150mM NaCl, 1mM eth-
ylenediaminetetraacetic acid (EDTA), 1mM ethylenegly-
coltetraacetic acid (EGTA), 1% Triton, 0.1% SDS, and 1%
protease inhibitor cocktail. Equal amounts (50µg) of pro-
teins were separated on 10%–12% SDS-polyacrylamide
gels in a minigel apparatus (Mini-PROTEAN II, Bio-Rad
Laboratories Inc., Hercules, CA, USA) and were then
transferred electrophoretically to nitrocellulose membranes.
The membranes were blocked with 5% milk in Tris-buﬀered
salinebeforeovernightincubationat4◦Cwithanti-SERCA2a
(1:1,000), anti-Na+-Ca2+ exchanger (1:1,000), anti-phos-
pholamban (1:1,000), and anti-GAPDH (1:1,000) anti-
bodies. Membranes were then incubated for 1hr with
horseradish peroxidase- (HRP-) conjugated secondary anti-
body (1:5,000). All other antibodies were obtained from
the Cell Signaling Technology (Beverly, MA, USA). After
immunoblotting, the ﬁlm was scanned, and the intensity of
immunoblot bands was detected with a Bio-Rad Calibrated
Densitometer. GAPDH was used as the loading control.
2.5. SERCA Activity Measured by 45Ca2+ Uptake. Cardiomy-
ocytes were sonicated and solubilized in a Tris-sucrose
homogenization buﬀer consisting of 30mM Tris-HCl, 8%
sucrose, 1mM PMSF and 2mM dithiothreitol, pH 7.1. To
determine SERCA-dependent Ca2+ uptake, samples were
treated with and without the SERCA inhibitor thapsigarginExperimental Diabetes Research 3
(10µM) for 15min. The diﬀerence between the two read-
ings was deemed the thapsigargin-sensitive uptake through
SERCA. Uptake was initiated by the addition of an aliquot
of supernatant to a solution consisting of (in mM) 100 KCl,
5N a N 3,6M g C l 2, 0.15 EGTA, 0.12 CaCl2, 30 Tris-HCl pH
7.0, 10 oxalate, 2 ATP, and 1µCi 45CaCl2 at 37◦C. Aliquots of
samples were injected onto glass ﬁlters on a suction manifold
and washed 3 times. Filters were then removed from the
manifold, placed in scintillation ﬂuid and counted. SERCA
activity was expressed as cpm/mg protein [23].
2.6. Statistical Analysis. For each experimental series, data
are presented as Mean ± SEM. Statistical signiﬁcance (P<
0.05) for each variable was estimated by analysis of variance
(ANOVA).
3. Results
3.1. Eﬀect of Short-Term Culture on Adult Rat Cardiomyocyte
Mechanical Properties. Our data shown in Figure 1 revealed
that 6 hours of incubation of high extracellular glucose did
not aﬀect any of the cell mechanics evaluated. Interestingly,
prolonged culturing in normal glucose medium signiﬁ-
cantly diminished peak shortening (PS) amplitude without
aﬀecting the resting cell length, maximal velocity of short-
ening/relengthening (±dL/dt), time to PS (TPS), and time
to 90% relengthening (TR90). Following 12 hours of incu-
bation, high glucose medium signiﬁcantly decreased PS and
±dL/dt, as well as prolonged TPS and TR90.
3.2. Impact of Glycation or Translation Inhibition on High
Glucose-Induced Cardiomyocyte Mechanical Anomalies. To
examine the potential mechanism(s) behind the high
glucose-induced cardiomyocyte contractile abnormalities,
the glycation inhibitor aminoguanidine (1mM), or the
translation inhibitor cycloheximide was coincubated with
adult rat cardiomyocytes for 12 hours maintained in either
normal or high glucose medium. Our data depicted that
both aminoguanidine and cycloheximide signiﬁcantly atten-
uated or mitigated the high glucose-induced cardiomyocyte
mechanical anomalies (without aﬀecting resting cell length).
Neither inhibitor aﬀected cardiomyocyte contractile proper-
tiesbyitself(Figure 2).Thesedatadepictedapotentialroleof
glycation and protein translation in glucose toxicity-induced
cardiomyocyte contractile defects.
3.3. Impact of Elevated Extracellular Ca2+ Concentration on
High Glucose-Induced Cardiomyocyte Mechanical and Intra-
cellularCa2+ HandlingDerangements. Theabove-mentioned
data were collected under an extracellular Ca2+ concentra-
tion of 1mM. To evaluate if facilitated intracellular Ca2+
dynamics with elevated extracellular Ca2+ levels on high
glucose-induced response in cardiomyocyte mechanics, Ca2+
concentration was raised from 1mM to 2.7mM in the
recording contractile buﬀer. Data shown in Figure 3 revealed
that elevated extracellular Ca2+ signiﬁcantly improved car-
diomyocyte contractile capacity in cells maintained in both
normal and high glucose environments. PS and ±dL/dt were
overtly elevated in response to elevated extracellular Ca2+
level associated with unchanged resting cell length, TPS, and
TR90. Interestingly, high glucose-induced abnormalities in
cardiomyocyte contractile abnormalities seen at the extracel-
lular Ca2+ level of 1mM were abolished when extracellular
Ca2+ levels were raised to 2.7mM. To evaluate the potential
mechanism of action underlying high extracellular Ca2+-
induced beneﬁcial eﬀect against glucose toxicity-induced
cardiomyocytemechanicalresponses,intracellularCa2+ han-
dling was evaluated using the fura-2 ﬂuorescence dye.
Our data indicated that high extracellular Ca2+ promoted
intracellular Ca2+ handling in both normal and high glucose
environments [elevated resting, peak and change of fura-2
ﬂuorescence intensity (FFI)] associated with unchanged
intracellular Ca2+ decay. Similar to the mechanical response,
elevated extracellular Ca2+ levels eﬀectively attenuated or
nulliﬁedglucosetoxicity-inducedderangementofintracellu-
lar Ca2+ handling (delayed intracellular Ca2+ clearance with
unchanged baseline, peak and increase in FFI) (Figure 4).
3.4. Impact of Elevated Extracellular Ca2+ on High Glucose-
Induced Changes in Intracellular Ca2+ Regulatory Proteins
in Cardiomyocytes. To further evaluate elevated extracellular
Ca2+ and high glucose-induced changes in intracellular
Ca2+ handling, expression of intracellular Ca2+ regulatory
protein was evaluated. Our results revealed that neither
high extracellular Ca2+ nor high glucose, or both, produced
any notable changes in the levels of SERCA2a, Na+-Ca2+
exchanger and phospholamban. However, measurement of
SERCA activity revealed that high extracellular glucose
signiﬁcantly dampened the thapsigargin-sensitive 45Ca2+
uptake under low extracellular Ca2+ environment, the eﬀect
of which was nulliﬁed by elevated extracellular Ca2+.L a s t
but not least, increase in extracellular Ca2+ concentration
itselfdidnotaﬀectexpressionoractivityofintracellularCa2+
regulatory proteins (Figure 5).
3.5. Eﬀect of CaM Kinase Inhibition on Elevated Extracellular
Ca2+-Induced Protection against Glucose Toxicity. Elevated
extracellular Ca2+ levels are known to activate CaM kinase.
To evaluate if CaM kinase plays a role in the elevated
extracellular Ca2+ concentration-induced beneﬁcial eﬀect
against glucose toxicity, cardiomyocytes maintained in nor-
mal or high glucose medium were recorded in low or high
extracellularCa2+ environmentsintheabsenceorpresenceof
the CaM kinase inhibitor KN93 (10µM). Our data revealed
that KN93 eﬀectively abolished high extracellular Ca2+-
oﬀered protection against high glucose-induced cardiomy-
ocyte contractile anomalies (decrease in PS and ±dL/dt as
well as prolonged TPS and TR90). In addition, KN93 also
abolished high extracellular Ca2+-induced cardiomyocyte
contractile responses (increased PS and ±dL/dt along with
unchanged TPS and TR90)u n d e rl o we x t r a c e l l u l a rC a 2+
environment (Figure 6).
4. Discussion
Result from our study revealed that elevated extracellular
Ca2+ level mitigated the glucose toxicity-induced cardiomy-
ocyte mechanical and intracellular Ca2+ anomalies. Glucose4 Experimental Diabetes Research
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Figure 1: Mechanical property of adult rat cardiomyocytes cultured for 6 and 12 hours in a serum-free medium with normal glucose (NG:
5.5mM) or high glucose (HG: 25.5mM). (a) Resting cell length, (b) peak shortening (PS) amplitude normalized to cell length, (c) maximal
velocity of shortening (+dL/dt), (d) maximal velocity of relengthening (−dL/dt), (e) time to PS (TPS), and (f) time to 90% relengthening
(TR90). Mean ± SEM, n = 24 and 41-42 cells per group at 6 and 12 hours, respectively, ∗P<0.05 versus NG-6 Hr group, #P<0.05 versus
NG-12 Hr group.
toxicityorelevatedextracellularglucoselevelhasbeenshown
to compromise cardiomyocyte contractile function and
intracellular Ca2+ homeostasis following short-term expo-
sure [24, 25], suggesting a role of hyperglycemia in cardiac
contractileanomalies.Interestingly,ourﬁndingrevealedthat
the high extracellular Ca2+-induced beneﬁt eﬀect against
glucose toxicity was abolished by the CaM kinase inhibitor
KN93, suggesting a role of CaM kinase in elevated extracel-
lular Ca2+-induced beneﬁcial eﬀect against glucose toxicity.
Hyperglycemia has been shown to be one of the most
devastating predisposing factors for the onset and devel-
opment of diabetic cardiomyopathy [2–4, 24]. Reduced
cardiac contractility, depressed maximal velocity of contrac-
tion/relaxation, and prolonged contraction/relaxation are
considered landmarks of hyperglycemia or diabetes-induced
myopathic alterations [2, 4, 7, 8, 24]. Findings from this
study conﬁrmed our earlier observations that cardiomy-
ocytes maintained in high glucose medium for 12 hours (butExperimental Diabetes Research 5
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Figure2:Mechanicalpropertyofadultratcardiomyocytesculturedfor12hoursinaserum-freemediumwithnormalglucose(NG:5.5mM)
or high glucose (HG: 25.5mM) in the absence or presence of the glycation inhibitor aminoguanidine (1mM) or the translation inhibitor
cycloheximide (60µm). DMSO was used as a solvent with a ﬁnal concentration less than 0.5%. (a) Resting cell length, (b) peak shortening
(PS) amplitude normalized to cell length, (c) maximal velocity of shortening (+dL/dt), (d) maximal velocity of relengthening (−dL/dt); (e)
time to PS (TPS), and (f) time to 90% relengthening (TR90). Mean ± SEM, n = 22–29 cells per group, ∗P<0.05 versus NG group, #P<0.05
versus HG group.
not 6 hours) compromised cardiomyocyte mechanical prop-
erties manifested as depressed peak shortening and maxi-
mal velocity of shortening/relengthening, along with pro-
longed duration of contraction and relaxation, in a manner
similar to in vivo diabetes [6, 24, 25]. The subtle diﬀerence in
contractile capacity in NG-maintained cardiomyocytes (Fig-
ures 1 and 6) may be largely due to interculture and/or indi-
vidual murine variations. Earlier studies from our laboratory6 Experimental Diabetes Research
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Figure 3: Mechanical property of adult rat cardiomyocytes maintained for 12 hours in a serum-free medium with normal glucose (NG:
5.5mM) or high glucose (HG: 25.5mM) in the absence or presence of high extracellular Ca2+ (Hi-Ca, 2.7mM) in the contractile buﬀer. An
extracellularCa2+ concentrationof1.0mMwasusedasthenormallowCa2+ (LoCa)environment.(a)Restingcelllength(b)peakshortening
(PS) amplitude normalized to cell length; (c) Maximal velocity of shortening (+dL/dt); (d) Maximal velocity of relengthening (−dL/dt), (e)
time to PS (TPS), and (f) time to 90% relengthening (TR90). Mean ± SEM, n = 38–42 cells per group, ∗P<0.05 versus NG-LoCa group,
#P<0.05 versus HG-LoCa group.
have established that normal cardiomyocytes may display
diabetes-like phenotype of cardiac mechanical dysfunctions
simulating in vivo diabetes after only 12–24 hours of culture
in a serum-free high glucose medium [18, 24, 25]. The use of
isolated cardiomyocyte model allows the precise control of
the extracellular milieu in which cardiomyocytes reside, thus
maximally eliminating the possible interference from ﬁbrob-
lasts,endothelialmetabolism,anddiﬀusionbarriers[25–27].
Intriguingly, the glycation inhibitor aminoguanidine and
the translation inhibitor cycloheximide attenuated glucose
toxicity-induced cardiomyocyte contractile defects without
eliciting anyeﬀectby themselves. These ﬁndings suggest pos-
sible involvement of glycation and protein translation in glu-
cose toxicity-induced cardiac contractile anomalies. Earlier
ﬁndings from our laboratory as well as others have depicted
a pivotal role of glycation in hyperglycemia and diabetes-
inducedcardiacdysfunctions[5,6,28,29].Furthermore,our
data revealed that glucose toxicity-induced cardiomyocyteExperimental Diabetes Research 7
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Figure 4: Intracellular Ca2+ handling property of adult rat cardiomyocytes cultured for 12 hours in a serum-free medium with normal
glucose (NG: 5.5mM) or high glucose (HG: 25.5mM) in the absence or presence of high extracellular Ca2+ (Hi-Ca, 2.7mM) in the
contractilebuﬀer.AnextracellularCa2+ concentrationof1.0mMwasusedasthelowCa2+ (LoCa)environment.(a)RestingintracellularCa2+
levels shown as baseline fura-2 ﬂuorescent intensity (FFI), (b) peak FFI, (c) electrically stimulated rise of FFI (ΔFFI), and (d) intracellular
Ca2+ decay rate. Mean ± SEM, n = 29–42 cells per group, ∗P<0.05 versus NG-LoCa group, #P<0.05 versus HG-LoCa group.
anomalies may be abolished with elevated extracellular Ca2+
levels (from the physiological level of 1.0mM to 2.7mM),
the eﬀect of which may be abolished by inhibition of CaM
kinase using KN93. Several mechanisms may be speculated
for elevated extracellular Ca2+-induced protection against
glucose toxicity. Elevated extracellular Ca2+ levels are capable
of facilitating cytosolic Ca2+ cycling and dynamics thus
promoting Ca2+ inﬂux and resequestration, regardless of
the extracellular glucose environment. This is supported by
the increased rise of intracellular Ca2+ in response to elec-
trical stimuli, facilitated intracellular Ca2+ decay, improved
SERCA activity (although not expression), and shortened
TR90 under high extracellular Ca2+ environment. Our
observation of depressed cardiomyocyte contractile capac-
ity and maximal velocity of contraction/relaxation along
with prolonged duration of contraction and relaxation in
high glucose-treated cardiomyocytes is supported by com-
promised intracellular Ca2+ handling under high glucose
environment, consistent with the ﬁndings from in vivo dia-
betic condition [8, 26]. Another scenario may be related to
changes in cardiac energy dynamics through CaM kinase
signaling cascade. Ca2+ ions promote cell survival through
a CaM kinase-dependent activation of Akt [30], in line
with the ﬁnding from our current study. If energy states
were the sole determinant of cardiac contractile function,
thennormalglucose-culturedcardiomyocytesshoulddisplay
improved cardiac contractile performance, consistent with
our experimental ﬁnding. One of the main mechanisms that
extracellular Ca2+ improves cardiac performance is through
increased phosphorylation state. It may be speculated that
Ca2+ ions promote contractile inotropism ﬁrst by bolstering
cardiac energy state, which occurs rapidly within minutes.
The CaM kinase cascade is essential to many physiological
processes, the defect of which can lead to a variety of disease
states. Calmodulin acts as a primary receptor for Ca2+ in all
eukaryotic cells whereas Ca2+/CaM kinase functions as an
allosteric activator of a host of enzymatic proteins [15]. The
area CaM-dependent kinase cascade is just on the horizon.
Further investigation on the cellular machineries in par-
ticular cardiac excitation-transcription coupling regulated8 Experimental Diabetes Research
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Figure 5: Expression of intracellular Ca2+ regulatory proteins in rat cardiomyocytes cultured for 12 hours in a serum-free medium with
normal glucose (NG: 5.5mM) or high glucose (HG: 25.5mM) in the absence or presence of high extracellular Ca2+ (Hi-Ca, 2.7mM) in
the recording contractile buﬀer. An extracellular Ca2+ concentration of 1.0mM was used as the normal low Ca2+ (LoCa) environment. (a)
Representative gel blots depicting levels of SERCA2a, Na+-Ca2+ exchanger, phospholamban, and GAPDH (loading control), (b) SERCA2a
expression,(c)Na+-Ca2+ exchangerexpression,(d)phospholambanexpression,and(e)SERCAactivitymeasuredusing 45Ca2+ uptake.Mean
± SEM, n = 6-7 isolations per group, ∗P<0.05 versus NG-LoCa group, #P<0.05 versus HG-LoCa group.Experimental Diabetes Research 9
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Figure 6: Mechanical property of rat cardiomyocytes cultured for 12 hours in a serum-free medium with normal glucose (NG: 5.5mM)
or high glucose (HG: 25.5mM) in the absence or presence of high or low extracellular Ca2+ (Hi-Ca = 2.7mM; LoCa = 1.0mM) in the
recording contractile buﬀer. A cohort of HG-cultured cardiomyocytes was recorded in high Ca2+ environment in the presence of the CaM
kinase inhibitor KN93 (10µM). (a) Resting cell length, (b) peak shortening (PS) amplitude normalized to cell length, (c) maximal velocity
of shortening (+dL/dt), (d) maximal velocity of relengthening (−dL/dt), (e) time to PS (TPS), and (f) time to 90% relengthening (TR90).
Mean ± SEM, n = 10 cells per group, ∗P<0.05 versus NG-LoCa group, #P<0.05 versus HG-LoCa group, †P<0.05 versus NG-HCa-KN93
group.10 Experimental Diabetes Research
by this intracellular Ca2+-initiated signaling cascade should
hold considerable promise for the future of disease-related
research [31].
In summary, the ﬁndings fromthe present study revealed
improved cardiac contractile and intracellular Ca2+ home-
ostasis against glucose toxicity. Considering the unique role
of CaM kinase in regulation of cardiac energy metabolism
and survival, understanding the mechanism of action of
CaM kinase in myocardial contractile regulation under
pathological conditions such as hyperglycemia should be
essential in the elucidation of CaM kinase in diabetic com-
plications.
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